Lincoln Pharmaceuticals Limited (NSE:LINCOLN)

Lincoln Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	11,851	11,725	6,784	6,230	4,494	2,676
Market Cap Growth	29.24%	72.84%	8.89%	38.64%	67.94%	-37.05%
Enterprise Value	9,890	10,027	5,679	5,224	3,624	2,441
Last Close Price	593.20	584.68	337.47	307.44	221.71	127.45
PE Ratio	13.26	12.57	9.31	8.98	7.22	5.20
PS Ratio	1.98	2.02	1.33	1.32	1.06	0.69
PB Ratio	1.85	1.98	1.35	1.44	1.23	0.85
P/TBV Ratio	1.85	1.98	1.35	1.44	1.23	0.88
P/FCF Ratio	-	49.39	27.13	20.36	7.43	3.95
P/OCF Ratio	-	18.55	17.28	8.18	6.49	3.55
EV/Sales Ratio	1.66	1.73	1.11	1.11	0.85	0.63
EV/EBITDA Ratio	10.67	10.02	6.34	5.46	4.16	3.73
EV/EBIT Ratio	12.20	11.19	7.05	5.96	4.54	4.18
EV/FCF Ratio	-	42.23	22.71	17.07	5.99	3.61
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.00	0.02
Debt / EBITDA Ratio	0.01	0.01	0.02	0.02	0.01	0.08
Debt / FCF Ratio	-	0.05	0.08	0.07	0.01	0.08
Asset Turnover	-	0.90	0.91	0.96	1.01	1.02
Inventory Turnover	-	3.84	3.44	3.72	4.29	4.45
Quick Ratio	-	3.32	3.39	2.56	2.74	2.25
Current Ratio	-	4.84	5.09	3.90	4.07	3.78
Return on Equity (ROE)	-	17.04%	15.59%	17.36%	18.31%	17.65%
Return on Assets (ROA)	-	8.70%	8.97%	11.11%	11.85%	9.65%
Return on Capital (ROIC)	8.54%	10.20%	10.72%	13.67%	14.55%	11.73%
Return on Capital Employed (ROCE)	-	14.70%	15.60%	19.80%	21.20%	18.00%
Earnings Yield	7.54%	7.96%	10.75%	11.13%	13.85%	19.22%
FCF Yield	-	2.02%	3.69%	4.91%	13.47%	25.31%
Dividend Yield	0.30%	0.31%	0.44%	0.49%	0.68%	1.18%
Payout Ratio	-	3.22%	4.12%	4.33%	-	11.66%
Buyback Yield / Dilution	-0.02%	-	-	-	-0.15%	-
Total Shareholder Return	0.28%	0.31%	0.44%	0.49%	0.53%	1.18%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.